MYCN
MYCN (N-myc proto-oncogene protein, also known as bHLHe37, N-myc and NMYC) is a nuclear basic helix-loop-helix transcription factor of the MYC family. Amplification of the MYCN gene is associated with a variety of tumours, most notably neuroblastoma. Browse Assay Genie's current range of MYCN research reagents below, or read on for the biology behind the target.
MYCN is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. The protein is located in the nucleus and must dimerise with another bHLH protein in order to bind DNA. In neuroblastoma cells, UniProt records that it positively regulates the transcription of MYCNOS, a gene that shares its locus.
The human MYCN gene encodes the N-myc proto-oncogene protein, which belongs to the basic helix-loop-helix group of proteins in HGNC classification. Multiple alternatively spliced transcript variants encoding different isoforms have been described for this gene, so researchers studying MYCN expression should consider which transcripts and isoforms are relevant to their work. Mouse and rat each carry an ortholog named Mycn.
The gene was originally named v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog, a name that reflects its relationship to the viral myc oncogene and its link to neuroblastoma. Other symbols and aliases include bHLHe37, N-myc, MYCNOT and NMYC. Amplification of the MYCN gene is associated with a variety of tumours, most notably neuroblastomas, which makes the protein a frequent subject in cancer biology. Researchers working with an MYCN antibody, MYCN ELISA kit or MYCN protein reagent are typically studying transcriptional control, tumour biology or MYC family function.
MYCN gene amplification is associated with tumours, most notably neuroblastomas, making the protein a central subject in studies of this cancer.
As a bHLH transcription factor that must dimerise with another bHLH protein to bind DNA, MYCN is studied in gene control.
MYCN is a member of the MYC family, so it is examined alongside related family members to understand shared and distinct functions.
Amplification of MYCN is linked to a variety of tumours, supporting work on how copy-number changes shape cancer biology.
MYCN is a nuclear basic helix-loop-helix transcription factor of the MYC family. It must dimerise with another bHLH protein to bind DNA. In neuroblastoma cells, it positively regulates transcription of MYCNOS, according to UniProt.
MYCN is also called N-myc, NMYC, bHLHe37 and MYCNOT, and was formerly named v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog. NCBI Gene reports multiple alternatively spliced transcript variants that encode different isoforms.
Amplification of the MYCN gene is associated with a variety of tumours, most notably neuroblastomas. Mouse and rat both have an ortholog called Mycn; check the datasheet of any product for its validated reactivity.
Other MYC family members, bHLH transcription factors and neuroblastoma-related targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P04198; product specifications from Assay Genie datasheets.